IMPORTANT MEDICAL & RESEARCH DISCLAIMER Important Medical & Research Disclaimer All Peptide Pen products are intended for laboratory and research purposes only and are not approved for human consumption, medical use, or therapeutic application
For growth hormone deficiency specifically: This is the medical indication CJC-1295 and ipamorelin gesture at without ever quite addressing
GLP-1 receptor agonists work by replicating the function of natural GLP-1, helping to restore these deficiencies
But because they have been used for longer as diabetes treatments, Al-Alys team studied the health records of more than two million people with diabetes in the Veterans Affairs database, some of whom were taking the GLP-1 medications and some who took other diabetes treatments
Safety Profile Cagrilintide has been studied in multiple Phase 2 and Phase 3 trials involving thousands of participants
A 2023 systematic review published in Frontiers in Endocrinology found that GLP-1 receptor agonists significantly improved weight, waist circumference, and insulin resistance markers in women with PCOS, reinforcing their growing role in metabolic management